-
Trauma in wartime is especially high risk given the nature of the injuries, the high risk of infection, and the limited access to optimal medical care.
-
In 1985, the newly fda-approved antimicrobial agent, Primaxin® (imipenem/cilastatin), introduced a new class of drugs known as carbapenems. This new class provided benefits as well as unwanted side effects. Carbapenems work similarly to other â-lactam antibiotics, but with substantially broader-spectrum of activity and better penetration into bacterial cell walls to prevent synthesis.
-
Eight hiv-infected patients (mean CD4+ t cell count 622 cells/uL) who had been receiving effective HAART for an average of 8.4 years were included in this study. PBMCs were obtained by leukapheresis and endoscopic terminal ileum biopsies were performed to obtain samples of Gut-Associated Lymphoid Tissue (GALT).
-
In This Issue: FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions.
-
Clinicians are becoming more attuned to the many complications of influenza, particularly with the high morbidity and mortality seen with H5N1 strains spreading around the world.
-
In this study, 12,765 patients from the large French Hospital Database on HIV with CD4+ lymphocyte counts < 200 cells/uL who received cART during 2000-2005 were selected.
-
It was recently reported that the prevalence of homozygosity for CCR5 delta 32, a nonfunctional variant of the chemokine receptor CCR5, is markedly increased among symptomatic WNV-seropositive patients from Arizona and Colorado.
-
Eosinophilic meningitis is a distinct clinical syndrome characterized, in part, by an eosinophilic pleocytosis in the cerebrospinal fluid (CSF).
-
-
In this issue: Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives?